科拓生物
(300858)
| 流通市值：25.45亿 | | | 总市值：34.25亿 |
| 流通股本：1.96亿 | | | 总股本：2.63亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 266,648,054.77 | 169,505,299.61 | 84,995,927.91 | 365,922,713.74 |
| 营业总成本 | 242,483,179.07 | 147,459,157.12 | 67,836,659.83 | 270,340,701.74 |
| 其他经营收益 | | | | |
| 营业利润 | 38,552,284.5 | 27,251,603.66 | 17,021,663.75 | 104,603,445.4 |
| 利润总额 | 38,486,546.36 | 27,253,970.08 | 17,023,290.38 | 103,829,959.52 |
| 净利润 | 35,754,839.19 | 25,096,983.6 | 14,951,299.74 | 94,519,402.43 |
| 每股收益 | | | | |
| 其他综合收益 | -0.01 | -4.84 | -4.64 | -19.81 |
| 综合收益总额 | 35,754,839.18 | 25,096,978.76 | 14,951,295.1 | 94,519,382.62 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 794,674,503.71 | 849,795,918.2 | 920,624,866.76 | 977,337,850.03 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,178,955,391.72 | 1,178,382,154.31 | 1,106,684,157.56 | 1,041,571,040.56 |
| 资产总计 | 1,973,629,895.43 | 2,028,178,072.51 | 2,027,309,024.32 | 2,018,908,890.59 |
| 流动负债: | | | | |
| 流动负债合计 | 159,471,673.74 | 186,959,620.49 | 119,054,078.4 | 127,600,280.46 |
| 非流动负债: | | | | |
| 非流动负债合计 | 52,367,875.43 | 49,196,290.13 | 50,475,564.01 | 48,480,523.32 |
| 负债合计 | 211,839,549.17 | 236,155,910.62 | 169,529,642.41 | 176,080,803.78 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,761,790,346.26 | 1,792,022,161.89 | 1,857,779,381.91 | 1,842,828,086.81 |
| 股东权益合计 | 1,761,790,346.26 | 1,792,022,161.89 | 1,857,779,381.91 | 1,842,828,086.81 |
| 负债和股东权益合计 | 1,973,629,895.43 | 2,028,178,072.51 | 2,027,309,024.32 | 2,018,908,890.59 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 317,228,558.27 | 194,283,605.4 | 89,978,579.51 | 447,875,156.93 |
| 经营活动现金流出小计 | 285,618,629.04 | 184,120,939.35 | 82,828,680.19 | 324,433,516.31 |
| 经营活动产生的现金流量净额 | 31,609,929.23 | 10,162,666.05 | 7,149,899.32 | 123,441,640.62 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,519,767,649.42 | 1,323,326,823.17 | 859,450,015.17 | 1,104,035,227.53 |
| 投资活动现金流出小计 | 1,377,863,556.21 | 1,055,886,825.21 | 756,767,729.26 | 1,193,002,361.22 |
| 投资活动产生的现金流量净额 | 141,904,093.21 | 267,439,997.96 | 102,682,285.91 | -88,967,133.69 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 117,787,673.72 | 50,881,485.88 | 416,094 | 40,413,537.49 |
| 筹资活动产生的现金流量净额 | -117,787,673.72 | -50,881,485.88 | -416,094 | -40,413,537.49 |
| 汇率变动对现金及现金等价物的影响 | -0.01 | -4.84 | -4.64 | -19.81 |
| 现金及现金等价物净增加额 | 55,726,348.71 | 226,721,173.29 | 109,416,086.59 | -5,939,050.37 |
| 期末现金及现金等价物余额 | 155,372,665.81 | 326,367,490.39 | 209,062,403.69 | 99,646,317.1 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 226,721,173.29 | - | -5,939,050.37 |